The importance of hydrolysis and N-oxidation in the in vitro metabolism of N-2-benzoyloxyethylnorfenfluramine (JP992--780SE)
Beckett, A.H.; Ogunbona, F.A.
Journal of Pharmacy and Pharmacology 25(Suppl): 170p
1973
ISSN/ISBN: 0022-3573 PMID: 4150581 Document Number: 69370
Document emailed within 1 workday
Related Documents
Gallaher, E.J.; Loomis, T.A. 1975: Metabolism of ethyl acetate in the rat: hydrolysis of ethyl alcohol in vitro and in vivo Toxicology and Applied Pharmacology 34(2): 309-313Edeki, T. 1996: Clinical importance of genetic polymorphism of drug oxidation Mount Sinai Journal of Medicine new York 63(5-6): 291-300
Sjöqvist, F.; von Bahr, C. 1973: Interindividual differences in drug oxidation: clinical importance Drug Metabolism and Disposition: the Biological Fate of Chemicals 1(1): 469-482
Keller, M.P.; Buri, P.; Charollais, E. 1992: The importance of digestive tract lipases in the hydrolysis of lipid excipients and substitution enzyme therapy. Part 1 Pharmaceutica Acta Helvetiae 67(2): 34-42
Zabelinskiĭ, E.A. 1970: Method of complex study of hydrolysis of polysaccharides in vivo and in vitro in humans Terapevticheskii Arkhiv 42(11): 101-107
Leat, W.M.; Lindsay, D.B.; Valerio, G. 1975: Oxidation and metabolism of linoleic acid in the sheep Proceedings of the Nutrition Society 34(2): 88A-89A
Ishikawa, M.; Ozaki, M.; Takayanagi, Y.; Sasaki, K. 1991: Doxapram inhibits the in vitro oxidation of hexobarbital Research Communications in Chemical Pathology and Pharmacology 72(3): 371-374
Lewis, R.W.; Olivier, G. 1977: In vitro oxidation of 6-MP and its metallo complexes by xanthine oxidase Research Communications in Chemical Pathology and Pharmacology 18(2): 377-380
Xu, B.; Cheng, W.; Lu, X. 1999: The effect of Xuezhikang on oxidation of low-density lipoproteins in vitro Zhonghua Nei Ke Za Zhi 38(8): 520-522
Kravchenko, L.V.; Kuz'mina, E.E.; Avren'eva, L.I.; Pozdniakov, A.L.; Kulakova, S.N.; Levachev, M.M. 1994: Effects of the degree of fish oil oxidation on the state of xenobiotic metabolism enzymes Voprosy Pitaniia 4: 13-16
Verweij, A.M.; Verheijden-de Bruyne, M.M. 1984: Hydrolysis of lorazepam with hydrochloric acid. Qualitative and quantitative analysis of byproducts of hydrolysis Archiv für Kriminologie 174(1-2): 35-39
Dayer, P.; Leemann, T.; Striberni, R.; Meyer, P. 1987: In vitro tests of hepatic oxidation in man, predictive of drug interactions Schweizerische Medizinische Wochenschrift 117(49): 1971-1973
Kawamura, M.; Hase, K.; Miyazaki, S. 1996: In vitro inhibition of low-density lipoprotein oxidation by a gemfibrozil metabolite Clinical Chemistry 42(4): 644-645
Grosa, G.; Rocco, F.; Ceruti, M.; Dosio, F.; Brusa, P.; Biglino, G. 1993: In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane, and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study Farmaco 48(5): 677-690
Behr, P.; Meyer, E.; Wurtz, B. 1976: The endogenous metabolism of Pseudomonas fluorescens in relation to the oxidation of ethanol, serine, and pyruvate Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 170(5): 1003-1008
Sasaki, N.; Morisaki, N.; Shinomiya, M.; Matsuoka, N.; Saito, Y.; Wakashin, M.; Ueda, S.; Kumagai, A. 1982: Effect of hypertension on lipid metabolism and beta-oxidation in rat aorta and brain microvessels Artery 11(2): 108-118
Tran, N. 1974: Automated radiometric assays of enzymatic and nonenzymatic oxidation of DOPA in vitro Journal of Laboratory and Clinical Medicine 84(2): 287-291
Barón, L.; López, F. 2000: Effect of arterial proteoglycans on in vitro oxidation of LDL isolated from hypercholesterolemic patients Acta Cientifica Venezolana 51(4): 211-222
Siekmeier, R.; Wülfroth, P.; Wieland, H.; Gross, W.; März, W. 1996: Low-density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers Clinical Chemistry 42(4): 524-530
Montesissa, C.; De Liguoro, M.; Amorena, M.; Lucisano, A.; Carli, S. 1995: In vitro comparison of aldicarb oxidation in various food-producing animal species Veterinary and Human Toxicology 37(4): 333-336